Study on the Pharmacokinetics and Bioavailability of Loratadine Tablets in Healthy Volenteers
Zhong Guo
Abstract
Zhong Guo
Abstract
OBJECTIVE: To study the pharmacokinetics and bioequivdent ofloratadine in healthy Volunteers. METHODS:A single oral dose 40mg loratadine ofreference or test preparations was given to healthy male volunteers according toan open randomized crossover study.The plasma concentrations of loratadine weredetermined by a RP HPLC method. The pharmacokinetic parameters and biovailabilityof test preparation were compared with reference preparation. RESULTS: The mainpharmacokinetic parameters of the reference and the test preparation were as follows:Cmax were 34.9±16.6μg.L-1and 33.5±l7.4μg.L-1; tmax were 0.76±0.24h and 0.75±0.26h;t(1/2)were l.63±0.48h and l.73±0.49h;AUC0-tn were 53.7±25.9μg.h.L-1 and48.8±2l.0μg.h.L-1; AUC0→∞were 58.5±28.0μg.h.L-1 and 54.6±23.8μg.h.L-1, Therelative bioavailability of reference to test preparation was 94.5 %±l4.5 %.CONCLUSION: The results of statistics analysis showed that the referencepreparation and the test preparation were bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To study the pharmacokinetics and bioequivdent ofloratadine in healthy Volunteers. METHODS:A single oral dose 40mg loratadine ofreference or test preparations was given to healthy male volunteers according toan open randomized crossover study.The plasma concentrations of loratadine weredetermined by a RP HPLC method. The pharmacokinetic parameters and biovailabilityof test preparation were compared with reference preparation. RESULTS: The mainpharmacokinetic parameters of the reference and the test preparation were as follows:Cmax were 34.9±16.6μg.L-1and 33.5±l7.4μg.L-1; tmax were 0.76±0.24h and 0.75±0.26h;t(1/2)were l.63±0.48h and l.73±0.49h;AUC0-tn were 53.7±25.9μg.h.L-1 and48.8±2l.0μg.h.L-1; AUC0→∞were 58.5±28.0μg.h.L-1 and 54.6±23.8μg.h.L-1, Therelative bioavailability of reference to test preparation was 94.5 %±l4.5 %.CONCLUSION: The results of statistics analysis showed that the referencepreparation and the test preparation were bioequivalent.
Key concepts: Bioequivalence, Loratadine, Pharmacokinetics, Bioavailability, Cmax, Crossover study, Pharmacology, Test preparation